OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Isabelle Aillaud, Susanne Aileen Funke
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 3, pp. 951-961
Open Access | Times Cited: 32
Isabelle Aillaud, Susanne Aileen Funke
Cellular and Molecular Neurobiology (2022) Vol. 43, Iss. 3, pp. 951-961
Open Access | Times Cited: 32
Showing 26-50 of 32 citing articles:
Recent Progress in the Treatment Strategies for Alzheimer’s Disease
Vinay Kumar, Kunal Roy
Neuromethods (2023), pp. 3-47
Closed Access | Times Cited: 2
Vinay Kumar, Kunal Roy
Neuromethods (2023), pp. 3-47
Closed Access | Times Cited: 2
Precision Proteoform Design for 4R Tau Isoform Selective Templated Aggregation
Andrew P. Longhini, Austin DuBose, Samuel Lobo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Andrew P. Longhini, Austin DuBose, Samuel Lobo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Pharmacological Potential of Bioactive Peptides for the Treatment of Diseases Associated with Alzheimer's and Brain Disorders
Jeetendra Kumar Gupta, Kuldeep Singh
Current Molecular Medicine (2023) Vol. 24, Iss. 8, pp. 962-979
Closed Access | Times Cited: 2
Jeetendra Kumar Gupta, Kuldeep Singh
Current Molecular Medicine (2023) Vol. 24, Iss. 8, pp. 962-979
Closed Access | Times Cited: 2
Novel Thiadiazole Derivatives as Potential Anti‐Alzheimer Agent: Synthesis, Activity of Molecular Interactions and their in Silico Assessment
Wen-Rong Du, Yong Lan, Xin-Yuan Guo, et al.
ChemistrySelect (2024) Vol. 9, Iss. 38
Closed Access
Wen-Rong Du, Yong Lan, Xin-Yuan Guo, et al.
ChemistrySelect (2024) Vol. 9, Iss. 38
Closed Access
Memantine/Rosuvastatin Therapy Abrogates Cognitive and Hippocampal Injury in an Experimental Model of Alzheimer's Disease in Rats: Role of TGF-β1/Smad Signaling Pathway and Amyloid-β Clearance
Esraa F. Zidan, Nesrine S. El-Mezayen, Safaa H. El‐Rewini, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 20, Iss. 1
Open Access
Esraa F. Zidan, Nesrine S. El-Mezayen, Safaa H. El‐Rewini, et al.
Journal of Neuroimmune Pharmacology (2024) Vol. 20, Iss. 1
Open Access
Novel Strategy for Alzheimer’s Disease Treatment through Oral Vaccine Therapy with Amyloid Beta
Yasunari Matsuzaka, Ryu Yashiro
Biologics (2023) Vol. 3, Iss. 1, pp. 23-39
Open Access | Times Cited: 1
Yasunari Matsuzaka, Ryu Yashiro
Biologics (2023) Vol. 3, Iss. 1, pp. 23-39
Open Access | Times Cited: 1
Amyloid Precursor Protein and Tau Peptides Linked Together Ameliorate Loss of Cognition in an Alzheimer’s Disease Animal Model
Ruth Maron, Yaron Vinik, Michael Tsoory, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12527-12527
Open Access
Ruth Maron, Yaron Vinik, Michael Tsoory, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12527-12527
Open Access
